Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial

This publication has 26 references indexed in Scilit:

• The Effect of Bisoprolol on Perioperative Mortality and Myocardial Infarction in High-Risk Patients Undergoing Vascular Surgery
  New England Journal of Medicine, 1999
• Drugs in the peri-operative period: 4 - Cardiovascular drugs
  Drug and Therapeutics Bulletin, 1999
• Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: Update of previous meta-analyses
  British Journal of Surgery, 1997
• The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke
  Published by Elsevier ,1997
• PHARMACOLOGICAL THROMBOPROPHYLAXIS IN HIP AND KNEE SURGERY: A SURVEY OF NEW ZEALAND ORTHOPAEDIC SURGEONS
  Anz Journal of Surgery, 1994
• Risk of and prophylaxis for venous thromboembolism in hospital patients. Thromboembolic Risk Factors (THRIFT) Consensus Group.
  BMJ, 1992
• Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis
  The Lancet, 1992
• Rapidity and duration of platelet suppression by enteric-coated aspirin in healthy young men
  The American Journal of Cardiology, 1992
• Deep venous thrombosis: a continuing problem.
  BMJ, 1988
• Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous Heparin
  New England Journal of Medicine, 1988